Advertisement

Topics

FDA OKs 1st Gene Therapy, Kymriah, for Use in U.S.

08:08 EDT 30 Aug 2017 | Drugs.com

WEDNESDAY, Aug. 30, 2017 -- The U.S. Food and Drug Administration broke new ground in cancer care Wednesday by approving the first gene therapy for patients in the United States. Kymriah (tisagenlecleucel) genetically tweaks a patient's own immune...

Original Article: FDA OKs 1st Gene Therapy, Kymriah, for Use in U.S.

NEXT ARTICLE

More From BioPortfolio on "FDA OKs 1st Gene Therapy, Kymriah, for Use in U.S."

Quick Search
Advertisement
 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...